Results 121 to 130 of about 5,648 (165)

[Costs of pharmacological treatment in hypertension and type 2 diabetes mellitus]. [PDF]

Rev Med Inst Mex Seguro Soc
Figueroa-García J, Granados-García VM, Martínez-Barro D, Figueroa-Hernández MF, Palomo-Piñón S, Rojano-Mejía D.   +5 more
europepmc   +1 more source

Implementation of a diabetic retinopathy referral network, Peru. [PDF]

Bull World Health Organ, 2018
Salamanca O, Geary A, Suárez N, Benavent S, Gonzalez M.   +4 more
europepmc   +1 more source

Comparing the effects of serum GPER-1 and oxidant/antioxidant levels on retinopathy in patients with diabetes and healthy individuals: a pilot study.

Arq Bras Oftalmol, 2022
Beyoğlu A, Kurutaş EB, Karaküçük Y, Çömez A, Meşen A.   +4 more
europepmc   +1 more source

Macular edema in retinal fundus images by a computational algorithm [PDF]

Rev Med Inst Mex Seguro Soc
Garrido-Pino CA, López-Montero LM, López-Lozano L, Hernández-González MA, Cruz-Aceves I.   +4 more
europepmc   +1 more source

[Agreement between the family doctor and the ophthalmologist in the evaluation of retinographies, when the former has ruled out diabetic retinopathy]. [PDF]

Aten Primaria, 2011
Jurado AM, Gallego Mdel C, Santacruz MV, Torres MP, González MP, Lozano JC.   +5 more
europepmc   +1 more source

[Diabetes mellitus: complications associated with time since diagnosis, health insurance, use of health services, and medication use, Brazilian National Health Survey 2019]. [PDF]

Cad Saude Publica
Leitão VBG, Andrade LG, Bacurau AGM, Assumpção D, Francisco PMSB.   +4 more
europepmc   +1 more source

Impact of the COVID-19 pandemic on the Andalusian program for early detection of diabetic retinopathy: a population-based study. [PDF]

Front Clin Diabetes Healthc
Ravé Garcia R, Rodríguez de Vera Gómez P, Mayoral Sánchez E, Aguilar Diosdado M, Martínez-Brocca MA.   +4 more
europepmc   +1 more source

Choroidal Nevi Prevalence in a Portuguese Population: Series of 80.000 Patients [PDF]

, 2010
Costa, E, Cristovão, LM, Proença, R
core  

The role of probiotics in modulating the gut microbiota as a potential inhibitor of diabetic kidney disease progression. [PDF]

J Bras Nefrol
Costa VCS, Pinheiro MM, Cabreira GT, Bustelli IB, Santos JF, Ventura S, Santos LSC, Vattimo MFF, Silva EO.   +8 more
europepmc   +1 more source